Armata Pharmaceuticals, Inc. (ARMP)

Armata Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	9.29	13.52	14.85	10.29	9.65
Cash & Short-Term Investments	9.29	13.52	14.85	10.29	9.65
Cash Growth	-31.30%	-8.95%	44.36%	6.62%	59.94%
Other Receivables	0.74	3.36	8.53	2.99	0.56
Receivables	0.74	3.36	8.53	2.99	0.56
Prepaid Expenses	1.27	2.27	3.66	1.72	0.64
Total Current Assets	11.31	19.15	27.05	15	10.85
Property, Plant & Equipment	54.93	57.28	46.65	38.07	12.84
Goodwill	3.49	3.49	3.49	3.49	3.49
Long-Term Deferred Charges	10.26	10.26	10.26	10.26	10.26
Other Long-Term Assets	6.46	8.19	8.39	2.96	2.09
Total Assets	86.44	98.36	95.83	69.77	39.52
Accounts Payable	0.77	1.59	1.68	1.14	0.96
Accrued Expenses	3.57	4.87	6.18	2.17	1.54
Short-Term Debt	-	-	-	-	0.72
Current Portion of Long-Term Debt	38.95	-	-	-	-
Current Portion of Leases	4.43	9.48	17.01	1.51	1.55
Other Current Liabilities	0.53	0.52	-	-	1.94
Total Current Liabilities	48.25	16.46	24.87	4.81	6.71
Long-Term Debt	55.44	82.31	-	-	-
Long-Term Leases	27.69	28.58	31.8	36.48	10.88
Long-Term Deferred Tax Liabilities	3.08	3.08	3.08	3.08	3.08
Total Liabilities	134.46	130.43	59.75	44.37	20.66
Common Stock	0.36	0.36	0.36	0.27	0.19
Additional Paid-In Capital	279.35	276.39	275.49	227.98	198.37
Retained Earnings	-327.74	-308.82	-239.77	-202.86	-179.7
Shareholders' Equity	-48.02	-32.07	36.08	25.4	18.86
Total Liabilities & Equity	86.44	98.36	95.83	69.77	39.52
Total Debt	126.52	120.37	48.82	37.99	13.15
Net Cash (Debt)	-117.22	-106.85	-33.96	-27.7	-3.5
Net Cash Per Share	-1.98	-2.96	-0.99	-1.15	-0.21
Filing Date Shares Outstanding	36.18	36.15	36.14	30.73	24.94
Total Common Shares Outstanding	36.18	36.12	36.14	27.11	18.69
Working Capital	-36.94	2.69	2.17	10.18	4.14
Book Value Per Share	-1.33	-0.89	1.00	0.94	1.01
Tangible Book Value	-51.51	-35.56	32.59	21.91	15.37
Tangible Book Value Per Share	-1.42	-0.98	0.90	0.81	0.82
Machinery	14.29	12.83	11.27	9.02	7.68
Construction In Progress	8.3	8.1	-	-	-
Leasehold Improvements	3.8	3.45	3.45	3.42	3.42

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q